We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.

Delisted

GNCA was delisted on the 2nd of June, 2022.

59 hedge funds and large institutions have $136M invested in Genocea Biosciences, Inc. in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $87.8M → $136M (+$47.8M)

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

4% more funds holding

Funds holding: 5759 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

Holders
59
Holders Change
+2
Holders Change %
+3.51%
% of All Funds
1.57%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
12
Increased
16
Reduced
16
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$496K -$297K -9,363 -54%
OAM
27
Oxford Asset Management
United Kingdom
$466K +$239K +7,528 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$464K
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$439K -$23.7K -747 -10%
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$355K +$23.5K +739 +15%
BC
31
Birchview Capital
Vermont
$302K +$155K +4,875 New
AA
32
ALPS Advisors
Colorado
$245K -$21.3K -672 -15%
TA
33
Teachers Advisors
New York
$242K
Charles Schwab
34
Charles Schwab
California
$207K
Morgan Stanley
35
Morgan Stanley
New York
$205K -$7.72K -243 -7%
Citigroup
36
Citigroup
New York
$202K +$68.4K +2,155 +196%
Millennium Management
37
Millennium Management
New York
$161K -$565K -17,786 -87%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$156K
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$154K
NFA
40
Nationwide Fund Advisors
Ohio
$107K
FMA
41
FNY Managed Accounts
New York
$106K +$54.6K +1,719 New
Goldman Sachs
42
Goldman Sachs
New York
$103K +$52.7K +1,658 New
Wells Fargo
43
Wells Fargo
California
$87K +$4.38K +138 +11%
AIG
44
American International Group
New York
$84K
EGA
45
Eagle Global Advisors
Texas
$83K +$42.7K +1,346 New
VOYA Investment Management
46
VOYA Investment Management
Georgia
$79K
BA
47
BlackRock Advisors
Delaware
$72K
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$43K -$11.8K -370 -21%
FNYS
49
First New York Securities
New York
$36.5K +$18.7K +590 New
Deutsche Bank
50
Deutsche Bank
Germany
$24K -$8.64K -272 -41%

GNCA Hedge Fund Activity: Q1 2016 in Review

59 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q1 2016, worth a combined $136M — up 54% from $87.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GNCA positions and 10 closed out — a net gain of 2 holders — while 16 added to existing stakes and 16 trimmed.

The largest buyer was Franklin Resources, adding an estimated $3.09M. The largest seller was Broadfin Capital, exiting entirely with an estimated $4.46M sold.

  • 59 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q1 2016, up from 57 in Q4 2015.
  • Funds reported $136M of Genocea Biosciences, Inc. stock for Q1 2016, up 54% quarter-over-quarter.
  • 12 funds opened new Genocea Biosciences, Inc. positions in Q1 2016 and 10 closed out, a net change of +2 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q1 2016 was Franklin Resources, an estimated $3.09M added.
  • The largest Genocea Biosciences, Inc. seller in Q1 2016 was Broadfin Capital, an estimated $4.46M sold.

Based on aggregated 13F filings for Q1 2016.